



My laboratory is trying to make
transgenic mosquitoes. We hope to
find out if it is possible to decrease
the transmission of infectious agents
(such as those that cause malaria,
which world-wide kills one person
every 20 seconds) by altering the
disease vector so that it is no longer a
suitable host. 
There are some indications that
this approach could be successful.
Dengue-virus-resistant mosquitoes
have been made at Colorado State
University using an antisense system
(which is unfortunately not
heritable). We’ve been working on
transforming mosquitoes for over five
years. What keeps us going, and what
are the consequences of taking on
such a risky project?
In an intellectual and scientific
sense, our project is no riskier than
many other efforts. But principal
investigators, postdoctoral fellows and
graduate students need to produce
results within timescales relevant to
grants and job offers. Although I
know we’ll develop a transformation
system some day, I can’t say exactly
when. So I, and the people in my lab,
face a career risk due to current views
on how public money should be
spent. Edward Lewis spent his whole
life working on the genetics of
segment determination in Drosophila,
and got a Nobel prize for it.
Nowadays, that work would probably
be considered too risky to fund.
The problem with setting out on
a research effort that may be
long-term, has few publishable
interim milestones and is difficult to
fund is that the scientific community
recognizes and rewards success, not
the accumulation of knowledge that
precedes success. Some research
groups develop creative strategies for
publishing incremental advances, but
their reviewers soon lose patience. 
The expectation of a ‘publication
gap’ when you start a risky project
has different effects on lab heads,
postdoctoral fellows, and graduate
students. A five-year project is well
beyond the scope of an aggressive
postdoc, but is just within reach of a
good graduate student. Is this a five-
year project or not? The uncertainty
frustrates everyone. You can see the
disillusionment set in. 
The effect on graduate students
is particularly brutal. They start out
eager to work on an important
problem, swayed by the nobility of
the cause and the enthusiasm of the
lab head. The lucky break is just
around the corner. But if it doesn't
happen in time, they are left
scrambling for publications. 
For lab heads with tenure, the
immediate career effect is not so
devastating. All we have to worry
about is lab morale, the competition
for funds, and the fact that we’re
forced to admit publicly and often
repeatedly that the latest experiment,
yet again, has failed. A friend
recently admitted that he used to
think that the problem with mosquito
transformation was the incompetence
of workers in the area; he now knows
better, but many of my colleagues
must secretly feel the same. 
Given all this, what motivates
someone to undertake a risky
project? All I can say is that the work
is important and it needs to get done.
This leaves me with the
uncomfortable feeling that ‘risky
science’ as a whole depends on the
quixotic whims and energy of a few
individuals. If so, then there is an
additional risk to science in that, one
day, there may be no one eager or
able to take up the challenge.
Some hopeful changes have
recently reduced the risks a little.
Grant-giving bodies are becoming
more aware of the need to fund
long-term research, and private
foundations (in our case the John D.
and Catherine T. MacArthur
Foundation) have been particularly
responsive. The MacArthur Network
on the Biology of Disease Vectors has
now formulated an action plan (see
http://klab.agsci.colostate.edu/mfnet/
mfnet.html) to make it easier both to
reach the final goal and to share
credit for success among all the
groups who contributed to it. 
Career and ego damage may be
even more important than funding
problems, however. A while ago, the
NIH initiated a program to fund
“high-risk, high-impact” science.
Remarkably, no one that I know of in
the mosquito community applied. As
money gets tighter, fewer people
are willing to take any risks at all. 
The funding changes and
networking arrangements also don’t
help postdocs and graduate students
with their need to show productivity
in the short term. I know of no good
solution to this problem. Many lab
heads try to give each student a low-
risk project to work on in parallel
with the risky experiments. But risky
science demands a lot of attention
and the low-risk projects often get
put off. And succeeding at such a
project isn’t enough to elevate
creative, hard-working risk-takers
above their risk-averse peers. True,
people in the field know what you’ve
done, but this doesn’t help when a
postdoc or graduate student applies
for a job. Strong recommendations
from lab heads have their limits.  
Science offers one the thrill
(described by Lewis Carroll) of
trying to hold two contradictory facts
in your mind at once. As the projects
that need doing become increasingly
difficult, we have to address the
contradictions in our attitude towards
risky projects. We urgently need to
find a scientific solution to the
problem of rewarding those who are
willing to take risks on our behalf.
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